Perspective Therapeutics, Inc. (CATX) Stock Grade

About Perspective Therapeutics, Inc.'s fundamentals

Perspective Therapeutics is a medical devices company with a market capitalization of $285.1 million that is currently unprofitable, having reported a net loss in its latest annual statement with a net margin of 0.0%. The company experienced a complete decline in year-over-year revenue, falling 100.0%, indicating no ongoing revenue generation from operations. The company does not pay a dividend, and traditional valuation metrics like P/E ratio and return on equity are not applicable given the loss-making status. This profile reflects a company in a challenging financial position without current profitability or revenue.